Annual EPS
-$1.94
+$6.42+76.79%
31 December 2023
Summary:
CRISPR Therapeutics AG annual earnings per share is currently -$1.94, with the most recent change of +$6.42 (+76.79%) on 31 December 2023. During the last 3 years, it has risen by +$3.35 (+63.33%). CRSP annual EPS is now -141.28% below its all-time high of $4.70, reached on 31 December 2021.CRSP EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$1.01
+$0.48+32.21%
30 September 2024
Summary:
CRISPR Therapeutics AG quarterly earnings per share is currently -$1.01, with the most recent change of +$0.48 (+32.21%) on 30 September 2024. Over the past year, it has increased by +$0.40 (+28.37%). CRSP quarterly EPS is now -110.70% below its all-time high of $9.44, reached on 30 June 2021.CRSP Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$2.80
+$0.40+12.50%
30 September 2024
Summary:
CRISPR Therapeutics AG TTM earnings per share is currently -$2.80, with the most recent change of +$0.40 (+12.50%) on 30 September 2024. Over the past year, it has increased by +$1.67 (+37.36%). CRSP TTM EPS is now -155.01% below its all-time high of $5.09, reached on 30 June 2021.CRSP TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRSP EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +76.8% | +28.4% | +37.4% |
| 3 y3 years | +63.3% | +39.5% | -159.1% |
| 5 y5 years | +43.6% | -142.1% | -508.7% |
CRSP EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -141.3% | +76.8% | -189.4% | +57.9% | -159.1% | +68.2% |
| 5 y | 5 years | -141.3% | +76.8% | -110.7% | +57.9% | -155.0% | +68.2% |
| alltime | all time | -141.3% | +76.8% | -110.7% | +57.9% | -155.0% | +68.2% |
CRISPR Therapeutics AG EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.01(-32.2%) | -$2.80(-12.5%) |
| June 2024 | - | -$1.49(+4.2%) | -$3.20(+19.0%) |
| Mar 2024 | - | -$1.43(-226.5%) | -$2.69(+39.4%) |
| Dec 2023 | -$1.94(-76.8%) | $1.13(-180.1%) | -$1.93(-56.8%) |
| Sept 2023 | - | -$1.41(+43.9%) | -$4.47(-15.7%) |
| June 2023 | - | -$0.98(+46.3%) | -$5.30(-21.1%) |
| Mar 2023 | - | -$0.67(-52.5%) | -$6.72(-19.7%) |
| Dec 2022 | -$8.36(-277.9%) | -$1.41(-37.1%) | -$8.37(-4.9%) |
| Sept 2022 | - | -$2.24(-6.7%) | -$8.80(+6.9%) |
| June 2022 | - | -$2.40(+3.4%) | -$8.23(-328.0%) |
| Mar 2022 | - | -$2.32(+26.1%) | $3.61(-18.3%) |
| Dec 2021 | $4.70(-188.8%) | -$1.84(+10.2%) | $4.42(-6.8%) |
| Sept 2021 | - | -$1.67(-117.7%) | $4.74(-6.9%) |
| June 2021 | - | $9.44(-725.2%) | $5.09(-190.1%) |
| Mar 2021 | - | -$1.51(-0.7%) | -$5.65(+6.8%) |
| Dec 2020 | -$5.29(-552.1%) | -$1.52(+15.2%) | -$5.29(+62.3%) |
| Sept 2020 | - | -$1.32(+1.5%) | -$3.26(-808.7%) |
| June 2020 | - | -$1.30(+13.0%) | $0.46(-38.7%) |
| Mar 2020 | - | -$1.15(-325.5%) | $0.75(-22.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $1.17(-134.0%) | $0.51(-78.8%) | $0.97(-310.9%) |
| Sept 2019 | - | $2.40(-337.6%) | -$0.46(-88.3%) |
| June 2019 | - | -$1.01(+8.6%) | -$3.93(+5.1%) |
| Mar 2019 | - | -$0.93(+1.1%) | -$3.74(+9.0%) |
| Dec 2018 | -$3.44(+101.2%) | -$0.92(-14.0%) | -$3.43(+37.2%) |
| Sept 2018 | - | -$1.07(+30.5%) | -$2.50(+22.0%) |
| June 2018 | - | -$0.82(+32.3%) | -$2.05(+14.5%) |
| Mar 2018 | - | -$0.62(-6300.0%) | -$1.79(+4.7%) |
| Dec 2017 | -$1.71(-9.5%) | $0.01(-101.6%) | -$1.71(+32.6%) |
| Sept 2017 | - | -$0.62(+10.7%) | -$1.29(+24.1%) |
| June 2017 | - | -$0.56(+3.7%) | -$1.04(+14.1%) |
| Mar 2017 | - | -$0.54(-225.4%) | -$0.91(+38.2%) |
| Dec 2016 | -$1.89(+114.4%) | $0.43(-216.4%) | -$0.66(-56.3%) |
| Sept 2016 | - | -$0.37(-14.4%) | -$1.51(+11.3%) |
| June 2016 | - | -$0.43(+49.9%) | -$1.36(+46.7%) |
| Mar 2016 | - | -$0.29(-31.3%) | -$0.92(+45.3%) |
| Dec 2015 | -$0.88(+279.8%) | -$0.42(+93.3%) | -$0.64(+193.3%) |
| Sept 2015 | - | -$0.22 | -$0.22 |
| Dec 2014 | -$0.23 | - | - |
FAQ
- What is CRISPR Therapeutics AG annual earnings per share?
- What is the all time high annual EPS for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG annual EPS year-on-year change?
- What is CRISPR Therapeutics AG quarterly earnings per share?
- What is the all time high quarterly EPS for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG quarterly EPS year-on-year change?
- What is CRISPR Therapeutics AG TTM earnings per share?
- What is the all time high TTM EPS for CRISPR Therapeutics AG?
- What is CRISPR Therapeutics AG TTM EPS year-on-year change?
What is CRISPR Therapeutics AG annual earnings per share?
The current annual EPS of CRSP is -$1.94
What is the all time high annual EPS for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high annual earnings per share is $4.70
What is CRISPR Therapeutics AG annual EPS year-on-year change?
Over the past year, CRSP annual earnings per share has changed by +$6.42 (+76.79%)
What is CRISPR Therapeutics AG quarterly earnings per share?
The current quarterly EPS of CRSP is -$1.01
What is the all time high quarterly EPS for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high quarterly earnings per share is $9.44
What is CRISPR Therapeutics AG quarterly EPS year-on-year change?
Over the past year, CRSP quarterly earnings per share has changed by +$0.40 (+28.37%)
What is CRISPR Therapeutics AG TTM earnings per share?
The current TTM EPS of CRSP is -$2.80
What is the all time high TTM EPS for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high TTM earnings per share is $5.09
What is CRISPR Therapeutics AG TTM EPS year-on-year change?
Over the past year, CRSP TTM earnings per share has changed by +$1.67 (+37.36%)